Benzydamine


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult: PO Painful and inflammatory conditions of oropharynx As loz: Dissolve 1 loz slowly in the mouth tid. Alternatively, suck 1 loz 1-2 hourly or as needed (Max: 12 loz/day). Dosing may vary between countries, refer to detailed product guideline for specific dosing information. Max treatment duration: 7 days. Mouth/Throat Painful and inflammatory conditions of oropharynx As 0.15% w/v spray: 4-8 sprays 1.5-3 hourly. As 0.30% w/v spray: 2-4 sprays 1.5-3 hourly. As 0.15% w/v mouthwash or gargle: Rinse or gargle 15 mL 1.5-3 hourly as required. May dilute solution with equal volume of water if stinging occurs. Max treatment duration for all dosage forms: 7 days. Topical Pain and inflammation associated with musculoskeletal and joint disorders As 3% cream: Apply 35-85 mm (1-2 g) onto the affected area tid, or for up to 6 times/day at the prescriber's discretion in severe conditions. Max treatment duration: 10 days.
Contraindications
Hypersensitivity to benzydamine, aspirin, or other NSAIDs.
Special Precautions
Patient with existing or history of bronchial asthma, untreated bacterial throat infection. Renal and severe hepatic impairment. Children. Patient Counselling Cream: Avoid smoking or going near naked flames due to risk of burns.
Adverse Reactions
Significant: Local irritation and burning sensation. Rarely, bronchospasm. Gastrointestinal disorders: Oral hypoaesthesia, dry mouth; nausea, vomiting. Immune system disorders: Hypersensitivity reactions. Rarely, angioedema. Metabolism and nutrition disorders: Thirst. Nervous system disorders: Headache, drowsiness. Respiratory, thoracic and mediastinal disorders: Rarely, laryngospasm. Skin and subcutaneous tissue disorders: Photosensitivity reaction, rash, pruritus, erythema, papular eruption.
Potentially Fatal: Anaphylactic reaction.
ATC Classification
R02AX03 - benzydamine ; Belongs to the class of other throat preparations.
M01AX07 - benzydamine ; Belongs to the class of other non-steroidal antiinflammatory and antirheumatic products.
A01AD02 - benzydamine ; Belongs to the class of other agents for local oral treatment.
G02CC03 - benzydamine ; Belongs to the class of antiinflammatory products for vaginal administration used in the treatment and prevention of inflammation.
M02AA05 - benzydamine ; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains.
Disclaimer: This information is independently developed by CIMS based on benzydamine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in